CDKN2B and acute myeloid leukemia: Methylation changes in the 9p21 chromosomal regions consisting of the cyclin-dependent kinase inhibitor 2B (CDKN2B) and cyclin-dependent kinase inhibitor 2A (CDKN2A) genes have been frequently associated with myelodysplastic syndromes and AML.